Form 4: Insider Buys 475,000 Shares of Neuronetics
Statement of Changes in Beneficial Ownership
Jorey Chernett, a director and 10% owner of Neuronetics, Inc., acquired 475,000 shares of common stock in a series of transactions.
Summary
- Jorey Chernett, a director and 10% owner of Neuronetics, Inc. (STIM), purchased 475,000 shares of common stock on May 12, 2026.
- The shares were acquired at a weighted average price of $1.34 per share, with individual transaction prices ranging from $1.27 to $1.36.
- Following these transactions, Chernett beneficially owns 10,453,988 shares of common stock.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive filing due to the substantial purchase of shares by a key insider, indicating confidence in the company's future prospects.
Positives
- Significant insider purchase of 475,000 shares by a director and 10% owner, indicating strong conviction in the company's value.
- The purchase was made at prices reflecting a range of $1.27 to $1.36, suggesting opportunistic buying across different market levels.
- The reporting person, Jorey Chernett, holds a substantial beneficial ownership of 10,453,988 shares after the acquisition.
Future Outlook
No forward-looking statements or guidance are present in this filing.
Industry Context
StockSavvy.ai notes that significant insider buying, particularly by directors and large shareholders, is often interpreted as a bullish signal, suggesting that those with the most intimate knowledge of the company believe its stock is undervalued.
Stakeholder Impact
- Shareholders may view this significant insider purchase positively, potentially boosting confidence in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 05/12/2026 | Earliest transaction date and date of common stock purchase. |
| 05/13/2026 | Date of signature for the filing. |
Recommendation
holdWhile the insider purchase is a positive signal, a Form 4 filing solely reports a transaction and does not provide sufficient financial or strategic information to warrant a buy or sell recommendation. It suggests holding the position while awaiting more comprehensive company updates.
Keywords
Neuronetics, STIM, Form 4, Insider Trading, Stock Purchase, Beneficial Ownership, Director, 10% Owner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.